The first key finding was that obesity-induced ED is characterized by an impairment in flow-mediated vasodilation, which is mainly due to a dysfunction in eNOS, resulting in a loss of NO production, which is a principal vasodilatory and anti-inflammatory agent [20,162]. Here, NOS3 is linked to obesity due to melanocortin 4 receptor deficiency.